About Symposium

Graft versus host disease (GvHD) is a condition that may occur after allogeneic hematopoietic stem cell transplantation and is caused by complex interactions between donor and recipient immunity system. GvHD remains the major cause of death after hematopoietic stem cell transplantation and occurs in 40% to 60% of transplanted patients. Over the past few years, significant improvements have been made in the field of diagnosis and grading of GvHD, biomarkers associated with this complication, novel therapeutic approaches, etc. The purpose of "The First Franco-Iranian Symposium on Hematopoietic Stem Cell Transplantation: Updates in Approach to Graft versus Host Disease" that will be held in conjunction with “the 3rd National Festival and International Congress on Stem Cell and Regenerative Medicine” is sharing the new findings on pathobiology and grading of GvHD, different approaches for prevention of GvHD and new therapeutic approaches, new methods for diagnosis and monitoring of disease and etc. This event is dedicated to all physicians, nurses, researchers and other people who are engaged in HSCT and its complications. It is hoped that this symposium gather all colleagues and investigators who have a vital role in advances in this area, share their experiments and establish future collaborations.

Sponsors of the Festival

Scroll to Top